-
-
-
-
-
-
-
Ligand Pharma (LGND) Misses Q1 EPS by 21c
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $282 at Citi
-
-
-
-
-
-
-
Ligand Pharma (LGND) Tops Q4 EPS by 53c ; Offers Guidance
-
-
-
-
-
-
-
Pelthos Therapeutics acquires Xepi cream and raises $18 million
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $185 at RBC Capital
-
-
-
-
-
-
-
Ligand earns $5 million milestone as partner launches molluscum drug
-
-
-
-
-
-
-
Ligand Pharma (LGND) Leads $75 Million Royalty Financing in Castle Creek Biosciences
-
432,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

